Drugs / red cells
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT05638581 Comparator | Jul 2023 → Aug 2026 | — | University of Alabama at Birmingham | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 2
| Date | Issuer | Release |
|---|---|---|
| 2023-08-17 | Fresenius Kabi | Results Paving the Way for the Future of Blood Transfusions
Recently launched blood bag system not made with DEHP addresses market needs and is subject of an award-winning clinical study. fresenius-kabi.com ↗
The conclusion is that after storage, the quality and shelf-life of red cells is similar in the redesigned blood bag system compared to the ones currently in use. |
| 2013-12-09 | Agios Pharmaceuticals, Inc. | Results Agios Presents Preclinical Data from Lead Programs at American Society of Hematology Annual Meeting agios.com ↗
The results demonstrate that AG-348 potently activates a spectrum of PKR mutant proteins, the isoform of pyruvate kinase that is present in red blood cells, leading to a normalization of metabolic balance in patient-derived blood samples. |
All press releases naming this drug 2 releases
| Date | Issuer | Release |
|---|---|---|
| 2023-08-17 | Fresenius Kabi | Paving the Way for the Future of Blood Transfusions Recently launched blood bag system not made with DEHP addresses market needs and is subject of an award-winning clinical study. fresenius-kabi.com ↗ |
| 2013-12-09 | Agios Pharmaceuticals, Inc. | Agios Presents Preclinical Data from Lead Programs at American Society of Hematology Annual Meeting agios.com ↗ |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | red cells | “Participants will receive separated blood components (i.e., units of red cells, plasma, platelets, and cryoprecipitate) co-administered intravenously or intraosseously.” NCT05638581 ↗ |
| Route | Intravenous | “co-administered intravenously” NCT05638581 ↗ |